|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/20 | |
| A61K 38/12 | |||
| A61P 3/10 |
| (11) | Number of the document | 3443979 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18179669.9 |
| Date of filing the European patent application | 2012-03-09 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11305269 | 2011-03-11 | EP | |
| 201161451663 P | 2011-03-11 | US |
| (72) |
KLATZMANN, David, FR
SAADOUN, David, FR
CACOUB, Patrice, FR
ROSENZWAJG, Michčle, FR
PIAGGIO, Eliane, FR
BENSIMON, Gilbert, FR
BERNARD, Claude, FR
|
| (73) |
INSERM (Institut National de la Santé et de la Recherche Médicale),
101, rue de Tolbiac, 75013 Paris,
FR
Sorbonne Université, 21, rue de L`École de Médecine, 75006 Paris, FR ASSISTANCE PUBLIQUE - H PITAUX DE PARIS, 3, avenue Victoria, 75004 Paris, FR |
| (54) | IL-2 DOSAGE REGIMEN FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS |
| IL-2 DOSAGE REGIMEN FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS |